The boss of one of the world’s biggest pharma companies has defended the industry after President-elect Donald Trump’s share-denting comments in a press conference last week.
In an unprompted attack, Mr Trump took aim at US drug prices and the process by which they are set, saying that pharma was “getting away with murder,” leading some companies’ share prices to drop instantly by as much as 4%.
In an interview with US news channel CNBC at the World Economic Forum in Davos this week, Joe Jimenez, the chief executive of Novartis (NOVN: VX), was asked about Mr Trump’s comments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze